APA

Pradelli L., Calandriello M., Di V. R., Bellone M. & Tubaro M. (20160610). Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chicago

Pradelli L, Calandriello M, Di Virgilio R, Bellone M and Tubaro M. 20160610. Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Harvard

Pradelli L., Calandriello M., Di V. R., Bellone M. and Tubaro M. (20160610). Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

MLA

Pradelli L, Calandriello M, Di Virgilio R, Bellone M and Tubaro M. Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20160610.